Literature DB >> 35559891

Safe(r) by design guidelines for the nanotechnology industry.

Araceli Sánchez Jiménez1, Raquel Puelles2, Marta Perez-Fernandez2, Leire Barruetabeña3, Nicklas Raun Jacobsen4, Blanca Suarez-Merino5, Christian Micheletti5, Nicolas Manier6, Beatrice Salieri7, Roland Hischier8, Rositsa Tsekovska9, Yordan Handzhiyski9, Jacques Bouillard6, Yohan Oudart10, Karen S Galea11, Sean Kelly12, Neeraj Shandilya13, Henk Goede13, Julio Gomez-Cordon2, Keld Alstrup Jensen4, Martie van Tongeren14, Margarita D Apostolova9, Isabel Rodríguez Llopis3.   

Abstract

Expectations for safer and sustainable chemicals and products are growing to comply with the United Nations and European strategies for sustainability. The application of Safe(r) by Design (SbD) in nanotechnology implies an iterative process where functionality, human health and safety, environmental and economic impact and cost are assessed and balanced as early as possible in the innovation process and updated at each step. The EU H2020 NanoReg2 project was the first European project to implement SbD in six companies handling and/or manufacturing nanomaterials (NMs) and nano-enabled products (NEP). The results from this experience have been used to develop these guidelines on the practical application of SbD. The SbD approach foresees the identification, estimation, and reduction of human and environmental risks as early as possible in the development of a NM or NEP, and it is based on three pillars: (i) safer NMs and NEP; (ii) safer use and end of life and (iii) safer industrial production. The presented guidelines include a set of information and tools that will help deciding at each step of the innovation process whether to continue, apply SbD measures or carry out further tests to reduce uncertainty. It does not intend to be a prescriptive protocol where all suggested steps have to be followed to achieve a SbD NM/NEP or process. Rather, the guidelines are designed to identify risks at an early state and information to be considered to identify those risks. Each company adapts the approach to its specific needs and circumstances as company decisions influence the way forward.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Life cycle assessment; Nano-enabled products; Nanoform; Nanoparticles; Nanoscience; Risk assessment; Safer by design

Mesh:

Year:  2022        PMID: 35559891     DOI: 10.1016/j.impact.2022.100385

Source DB:  PubMed          Journal:  NanoImpact        ISSN: 2452-0748


  4 in total

Review 1.  Nanosafety: An Evolving Concept to Bring the Safest Possible Nanomaterials to Society and Environment.

Authors:  Filipa Lebre; Nivedita Chatterjee; Samantha Costa; Eli Fernández-de-Gortari; Carla Lopes; João Meneses; Luís Ortiz; Ana R Ribeiro; Vânia Vilas-Boas; Ernesto Alfaro-Moreno
Journal:  Nanomaterials (Basel)       Date:  2022-05-25       Impact factor: 5.719

2.  Inverse Boltzmann Iterative Multi-Scale Molecular Dynamics Study between Carbon Nanotubes and Amino Acids.

Authors:  Wanying Huang; Xinwen Ou; Junyan Luo
Journal:  Molecules       Date:  2022-04-27       Impact factor: 4.927

3.  The colony forming efficiency assay for toxicity testing of nanomaterials-Modifications for higher-throughput.

Authors:  Elise Rundén-Pran; Espen Mariussen; Naouale El Yamani; Elisabeth Elje; Eleonora Marta Longhin; Maria Dusinska
Journal:  Front Toxicol       Date:  2022-09-07

Review 4.  Resilience and efficiency for the nanotechnology supply chains underpinning COVID-19 vaccine development.

Authors:  Maureen S Golan; Emerson Mahoney; Benjamin Trump; Igor Linkov
Journal:  Curr Opin Chem Eng       Date:  2021-10-27       Impact factor: 6.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.